undamentalytics Newsletter

Bio Green Med Solution vs Inneova Holdings

Inneova Holdings is the larger business, with $58.4m of revenue in fiscal 2025 against $747,000 for Bio Green Med Solution (78.2 times as much). Bio Green Med Solution grew faster (1637.2% against -6.9%). Inneova Holdings kept more of each dollar of sales as profit: a net margin of -0.7% against -401.3%.

Latest fiscal yearBio Green Med SolutionBGMS, 2025Inneova HoldingsINEO, 2025
Revenue $747,000 $58.4m
Revenue growth 1637.2% -6.9%
Net income −$3.0m −$397,000
Operating margin — -0.1%
Net margin -401.3% -0.7%
Return on equity -128.4% -8.0%
Free cash flow −$4.8m $4.4m
Cash $3.5m $1.1m
Total debt $0 $18.9m
Debt to equity — 380.6%
Dividend per share — —
Dividend yield — —
Share buybacks — —
Employees — —
Market value $6.0m $9.0m
Price vs our value range — Below our value range
Moat score 8 (Weak) —
Insider trades, 12 months 0 buys, 1 sales 0 buys, 0 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.